Cargando…
The ocular adverse effects of oral drugs
Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs may cause irreversible loss of vision The risk of visual loss can be reduced by a num...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377292/ https://www.ncbi.nlm.nih.gov/pubmed/34421178 http://dx.doi.org/10.18773/austprescr.2021.028 |
_version_ | 1783740629066448896 |
---|---|
author | Ahmad, Rawan Mehta, Hemal |
author_facet | Ahmad, Rawan Mehta, Hemal |
author_sort | Ahmad, Rawan |
collection | PubMed |
description | Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs may cause irreversible loss of vision The risk of visual loss can be reduced by a number of approaches, including monitoring for ocular toxicity, reducing the drug dose, or stopping the drug and looking for an alternative. This can be supported by good communication between the prescribing clinician and ophthalmologist Infrequent or delayed ocular adverse effects may not be identified in clinical trials of new drugs. Reporting adverse events is therefore important |
format | Online Article Text |
id | pubmed-8377292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-83772922021-08-20 The ocular adverse effects of oral drugs Ahmad, Rawan Mehta, Hemal Aust Prescr Article Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs may cause irreversible loss of vision The risk of visual loss can be reduced by a number of approaches, including monitoring for ocular toxicity, reducing the drug dose, or stopping the drug and looking for an alternative. This can be supported by good communication between the prescribing clinician and ophthalmologist Infrequent or delayed ocular adverse effects may not be identified in clinical trials of new drugs. Reporting adverse events is therefore important NPS MedicineWise 2021-08-02 2021-08 /pmc/articles/PMC8377292/ /pubmed/34421178 http://dx.doi.org/10.18773/austprescr.2021.028 Text en 2020 NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Article Ahmad, Rawan Mehta, Hemal The ocular adverse effects of oral drugs |
title | The ocular adverse effects of oral drugs |
title_full | The ocular adverse effects of oral drugs |
title_fullStr | The ocular adverse effects of oral drugs |
title_full_unstemmed | The ocular adverse effects of oral drugs |
title_short | The ocular adverse effects of oral drugs |
title_sort | ocular adverse effects of oral drugs |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377292/ https://www.ncbi.nlm.nih.gov/pubmed/34421178 http://dx.doi.org/10.18773/austprescr.2021.028 |
work_keys_str_mv | AT ahmadrawan theocularadverseeffectsoforaldrugs AT mehtahemal theocularadverseeffectsoforaldrugs AT ahmadrawan ocularadverseeffectsoforaldrugs AT mehtahemal ocularadverseeffectsoforaldrugs |